Literature DB >> 11605935

Effects of mild hypothermia on blood-brain barrier disruption during isoflurane or pentobarbital anesthesia.

O Z Chi1, X Liu, H R Weiss.   

Abstract

BACKGROUND: This study was performed to determine whether mild hypothermia (32 degrees C) could attenuate the degree of blood-brain barrier (BBB) disruption caused by a hyperosmolar solution and whether the degree of disruption would vary depending on anesthetic agents.
METHODS: Rats were assigned to one of four groups: normothermic isoflurane, normothermic pentobarbital, hypothermic isoflurane, and hypothermic pentobarbital. During isoflurane (1.4%; normothermic or hypothermic) or pentobarbital (50 mg/kg administered intraperitoneally; normothermic or hypothermic) anesthesia, the external carotid artery and the femoral artery and vein were catheterized. Body temperature was maintained at 37 and 32 degrees C for the normothermic and hypothermic groups, respectively. To open the BBB, 25% mannitol was infused through the right carotid artery at the rate of 0.25 ml x kg(-1) x s(-1) for 30 s. The transfer coefficient of 14C-alpha-aminoisobutyric acid was determined.
RESULTS: Blood pressure was similar among the four groups of animals. The degree of the BBB disruption by hyperosmolar mannitol was less with isoflurane than pentobarbital anesthesia in the normothermic groups (transfer coefficient: 29.9 +/- 17.1 and 50.4 +/- 17.5 microl x g(-1) x min(-1) for normothermic isoflurane and pentobarbital, respectively; P < 0.05). Mild hypothermia decreased the BBB disruption during anesthesia with both anesthetic agents (hypothermic isoflurane: 9.8 +/- 8.3 microl x g(-1) x min(-1), P < 0.05 vs. normothermic isoflurane; hypothermic pentobarbital: 30.2 +/- 13.9 microl x g(-1) x min(-1), P < 0.05 vs. normothermic pentobarbital), but the disruption was less during isoflurane anesthesia (hypothermic isoflurane vs. hypothermic pentobarbital, P < 0.005). In the contralateral cortex, there were no significant differences among these four experimental groups.
CONCLUSIONS: The data demonstrated that hypothermia was effective in attenuating BBB disruption by hyperosmolar mannitol during isoflurane as well as pentobarbital anesthesia. The degree of disruption appeared smaller during isoflurane than during pentobarbital anesthesia in both the normothermic as well as the hypothermic groups.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11605935     DOI: 10.1097/00000542-200110000-00023

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  16 in total

Review 1.  Application of therapeutic hypothermia in the intensive care unit. Opportunities and pitfalls of a promising treatment modality--Part 2: Practical aspects and side effects.

Authors:  Kees H Polderman
Journal:  Intensive Care Med       Date:  2004-02-06       Impact factor: 17.440

Review 2.  Targeting the brain: rationalizing the novel methods of drug delivery to the central nervous system.

Authors:  Shailendra Joshi; Eugene Ornstein; Jeffrey N Bruce
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

Review 3.  Use of hypothermia in the intensive care unit.

Authors:  Jesse J Corry
Journal:  World J Crit Care Med       Date:  2012-08-04

4.  Inconsistent blood brain barrier disruption by intraarterial mannitol in rabbits: implications for chemotherapy.

Authors:  Shailendra Joshi; Aysegul Ergin; Mei Wang; Roberto Reif; Jane Zhang; Jeffrey N Bruce; Irving J Bigio
Journal:  J Neurooncol       Date:  2010-12-12       Impact factor: 4.130

Review 5.  Hyperosmolar blood-brain barrier opening using intra-arterial injection of hyperosmotic mannitol in mice under real-time MRI guidance.

Authors:  Chengyan Chu; Anna Jablonska; Yue Gao; Xiaoyan Lan; Wojciech G Lesniak; Yajie Liang; Guanshu Liu; Shen Li; Tim Magnus; Monica Pearl; Miroslaw Janowski; Piotr Walczak
Journal:  Nat Protoc       Date:  2021-12-13       Impact factor: 13.491

Review 6.  Application of therapeutic hypothermia in the ICU: opportunities and pitfalls of a promising treatment modality. Part 1: Indications and evidence.

Authors:  Kees H Polderman
Journal:  Intensive Care Med       Date:  2004-02-06       Impact factor: 17.440

Review 7.  Clinical applications of targeted temperature management.

Authors:  Sarah M Perman; Munish Goyal; Robert W Neumar; Alexis A Topjian; David F Gaieski
Journal:  Chest       Date:  2014-02       Impact factor: 9.410

Review 8.  Intracarotid delivery of drugs: the potential and the pitfalls.

Authors:  Shailendra Joshi; Phillip M Meyers; Eugene Ornstein
Journal:  Anesthesiology       Date:  2008-09       Impact factor: 7.892

9.  Therapeutic hypothermia: critical review of the molecular mechanisms of action.

Authors:  Fernando Pavel González-Ibarra; Joseph Varon; Elmer G López-Meza
Journal:  Front Neurol       Date:  2011-02-03       Impact factor: 4.003

Review 10.  Targeted temperature management for adult out-of-hospital cardiac arrest: current concepts and clinical applications.

Authors:  Tatsuma Fukuda
Journal:  J Intensive Care       Date:  2016-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.